Clinical trials: Diffuse Large B-Cell Lymphoma, open to volunteers

B-cell Non Hodgkin Lymphoma (NHL), DLBCL - Diffuse Large B Cell Lymphoma

A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma

• Recruiting
• Age: 18 to 75 years
• Early Phase 1
• Injection or infusion

This study is a single arm, open label, dose exploring clinical study to evaluate the safety, efficacy, metabolic kinetics and pharmacodynamics of CT1182 cells in patients with relapsed / refractory B-cell non Hodgkin lymphoma…

Conditions

B-cell Non Hodgkin Lymphoma (NHL), DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma (FL)

Trial name

NCT07548697

Testing

CT1182 injection

Where

China

Volunteers

24 people

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology